Chen Franco-Yehuda
2019
In 2019, Chen Franco-Yehuda earned a total compensation of $204.8K as CFO at Pluristem Therapeutics.
Compensation breakdown
| Salary | $78,889 |
|---|---|
| Stock Awards | $112,329 |
| Other | $13,599 |
| Total | $204,817 |
Franco-Yehuda received $112.3K in stock awards, accounting for 55% of the total pay in 2019.
Franco-Yehuda also received $78.9K in salary and $13.6K in other compensation.
Rankings
In 2019, Chen Franco-Yehuda's compensation ranked 13,433rd out of 13,971 executives tracked by ExecPay. In other words, Franco-Yehuda earned more than 3.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,433 out of 13,971 | 4th |
Division Manufacturing | 5,464 out of 5,701 | 4th |
Major group Chemicals And Allied Products | 2,127 out of 2,200 | 3rd |
Industry group Drugs | 1,827 out of 1,886 | 3rd |
Industry Biological Products, Except Diagnostic Substances | 383 out of 389 | 2nd |
Source: SEC filing on May 20, 2020.
Franco-Yehuda's colleagues
We found three more compensation records of executives who worked with Chen Franco-Yehuda at Pluristem Therapeutics in 2019.
News
Pluristem Therapeutics CEO Yaky Yanay's 2023 pay jumps 111% to $2.7M
May 1, 2024
Pluristem Therapeutics CEO Yaky Yanay's 2022 pay falls 86% to $1.3M
February 27, 2023
Pluristem Therapeutics Chairman Zami Aberman's 2020 pay falls 54% to $501K
April 8, 2021
Pluristem Therapeutics Chairman Zami Aberman's 2019 pay jumps 85% to $1.1M
May 20, 2020